CJC-1295 (No DAC) 9mg Easy Pen

CJC‑1295 (No DAC), also known as modified GRF (1‑29), is a designer analog of Growth Hormone Releasing Hormone (GHRH) that shows promising results in studies to stimulate the release of growth hormone from the pituitary gland.

Unlike the extended-release DAC version, this peptide purportedly mimics the body’s natural, pulsatile GH rhythms, creating short but effective spikes in GH, ideal for those looking to perform research on optimizing growth hormone signaling without continuous elevation. 

In studies, CJC‑1295 (No DAC) binds to the GHRH receptors in the anterior pituitary and:

• Triggers a short, natural GH pulse, similar to endogenous GHRH release.
• Minimizes cortisol, prolactin, and other stress hormone spikes, due to its targeted action and short duration.
• Stimulates IGF‑1 production in the liver, driving downstream anabolic and repair pathways.
• Studied for effects on lipolysis and metabolic function via episodic GH signaling.
• Supports sleep quality and tissue repair through nightly GH release patterns. 

Researchers study this peptide in connection with muscle growth, recovery, body composition, metabolism, and sleep, alongside questions of receptor sensitivity and tolerability. Because it’s short‑acting, during trials it’s typically dosed once or twice daily to coincide with exercise or circadian GH pulses.